Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma
City of Hope Medical Center
City of Hope Medical Center
Sumitomo Pharma America, Inc.
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
University of Athens
AIDS Malignancy Consortium
Jonsson Comprehensive Cancer Center
University of Arizona
M.D. Anderson Cancer Center
Swiss Cancer Institute
Memorial Sloan Kettering Cancer Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
SWOG Cancer Research Network
Dana-Farber Cancer Institute
University of Kansas Medical Center
UNC Lineberger Comprehensive Cancer Center
University of Rochester
French Innovative Leukemia Organisation
M.D. Anderson Cancer Center
Kantonsspital Aarau
University Hospital Plymouth NHS Trust
Augusta University
Amgen
National Cancer Institute (NCI)
City of Hope Medical Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Millennium Pharmaceuticals, Inc.